For those interested in such, these papers are being presented at the American Urological Association's 2019 Annual Meeting (AUA 2019), May 3 – 6, 2019 in Chicago, Illinois
urotoday.com/conference-hig...
AUA 2019: Too Old for a Prostate Biopsy?
AUA 2019: Health Care Spending in High Resource Prostate Cancer Patients: What Contributes Most to High Prostate Cancer Health Care Costs?
AUA 2019: Impact of Bone-Targeted Therapies in Patients with Chemotherapy-Naïve Metastatic Castration-Resistance Prostate Cancer on Enzalutamide: Post Hoc Analysis of PREVAIL
AUA 2019: Low Free Testosterone is an Independent Risk Factor for High Grade Prostate Cancer
AUA 2019: Decipher Biopsy Genomic Test Related to Gleason Grade Group Independent of Prostate Imaging Reporting and Data System
AUA 2019: A 30-Gene Hereditary Cancer Mutation Analysis Predicts Time to Biochemical Recurrence in Clinically Localized Prostate Cancer
AUA 2019: Predicting Clinically Significant Prostate Cancer: Combining 4Kscore and MRI
AUA 2019: Added Value of Concomitant Systematic Biopsies in Predicting Upgrading in Patients with Localized Prostate Cancer Diagnosed by MRI-targeted Biopsy: Implications for Treatment Selection
AUA 2019: Comparing the Diagnostic Accuracy of 68Ga-PSMA and 11C-choline PET/CT Scan According to PSA Level
AUA 2019: PSMA-PET in High-Risk nmCRPC SPARTAN-Like Patients Negative by Conventional Imaging
AUA 2019: How Accurate are Ga68-PSMA PET/CT and Multiparametric MRI in Excluding Pelvic Lymph Node Metastases Prior to Radical Prostatectomy?
AUA 2019: Diagnostic Efficacy of 18F-RHPSMA7 Positron Emission Tomography for N-staging of Patients with High Risk Primary Prostate Cancer
AUA 2019: PET/CT with 18F-fluciclovine to Predict Recurrence in Post-Treatment Prostate Cancer and its Role in Altering Treatment Plans
AUA 2019: Response to Apalutamide Among Patients with Nonmetastatic Castration-Resistant Prostate Cancer from SPARTAN by DECIPHER Genomic Classifier Score
AUA 2019: External Validation of the PREDICT Prostate Tool for Prognostication in nmCRPC: A Study from Prostate Cancer Database Sweden
AUA 2019: First Evaluation of One-Step Nucleic Acid Amplification (OSNA) For Rapid Molecular Detection of Lymph Node Metastases In Prostate Cancer Patients
AUA 2019: The Association Between Pathologic Features of Lymph Node Metastasis Identified After Prostatectomy and the Risk of Biochemical Recurrence: A Study of 280 Cases
AUA 2019: Assessing The Risk of Lymph Node Invasion with the New 2014 International Society of Urological Pathology Classification in Patients with Prostate Cancer Treated with Robotic Radical Prostatectomy and Lymph Node Dissection
AUA 2019: Survival Rates and Economic Outcomes in Chemotherapy-Naïve Metastatic Castrate Resistant Prostate Cancer Patients treated with Abiraterone Acetate or Enzalutamide
AUA 2019: Social Media Presence of United States Academic Urology Residency Programs
-Patrick